Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times UK
International Business Times UK
Health
Brian Yalung

GLP-1 Users Not Leaving Wellness Market But Redefining It, Study Suggests

Originally, GLP-1 (glucagon-like peptide-1) was meant for people dealing with type 2 diabetes. However, it has since expanded and has become a potential alternative for people dealing with obesity.

For those who may not be aware, GLP-1 is a natural hormone produced in the gut that regulates blood sugar and appetite. There is no question that these are key factors when it comes to weight-loss initiatives. However, there are still critical clinical and research gaps in structured nutritional guidance for its use, per Nature.com.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.